Table 1

- Laboratory investigations

Laboratory findingsValueReference range
CRP19.60 mg/L≤1.20 mg/L
Ferritin471.7 μg/L21.8-274.6 μg/L
LDH1210 U/L125-220 U/L
Creatinine72 μmol/L64-110 μmol/L
eGFR117 mL/min/1.73 m2≥60 mL/min/1.73 m2
PTT27.6 s21.8-29.4 s
PT16.5 s7.6-10.4 s
PT control10.0 s11.0-14.0 s
PT-Sec16.0 s11.6-14.6 s
INR1.80.8-1.2
PT-INR1.3*
D-dimer0.80 mg/L0.00-0.50 mg/L
WBCs12.20 x 109/L4-11 x 109/L
Neutrophils8.87 x 109/L2-7.5 x 109/L
Monocytes1.35 x 109/L0.1-1.1 x 109/L
RBCs6.30 x 1012/L4.5-6.1 x 1012/L
Hgb169 g/L135-180 g/L
Platelets351 x 103/mcL150-400 x 103/mcL
HCT0.544 L/L0.42-0.54 L/L
Free T48.7 pmol/L9.0-19.0 pmol/L
TSH6.78 mIU/L0.35-4.94 mIU/L
Serum BGP1 IgM4.51 SMU<20 SMU (-) and >20 SMU (+)
Serum BGP1 IgG0.60 SGU<20 SGU (-) and >20 SGU (+)
Serum BGP1 IgA2.11 SAU<20 SAU (-) and >20 SAU (+)
ACA total Ab IgA2.86 APL unit<12 APL unit (-), >80 APL unit strong (+)
ACA total Ab IgM18.55 MPL unit<12.5 MPL unit (-), >80 MPL unit strong (+)
ACA total Ab IgG4.76 GPL unit<15 GPL unit (-), >80 GPL unit strong (+)
LA141.7 s30-43 s
Lupus group anticoagNegative 
Factor V gene mutation (Leiden mutation)Wild type (“Leiden” mutation not detectable)
Prothrombin (factor II) mutationWild type (no mutation present)
Molecular genetic analysis of mutation c.1849G>T p.(V617F) in exon 14 of the JAK2 geneNot detected
  • *No treatment: >3.0, for patient on coumadin/warfarin therapy: >5.0, for thromboembolic states: 2.0-3.0, for artificial heart valves and recurrent embolism: 2.5-3.5, CRP: C-reactive protein, LDH: lactate dehydrogenase, eGFR: estimated glomerular filtration rate, PTT: partial thromboplastin time, PT: prothrombin time, INR: international normalization ratio, WBCs: white blood cells, RBCs: red blood cells, Hgb: hemoglobin, HCT: hematocrit, T4: thyroxine 4, TSH: thyroid stimulating hormone, BGP1: beta 2-glycoprotein 1, ACA total Ab: anti-cardiolipin antibody, LA1: Lupus group, s: second, SAU: surgical assessment unit, Ig: immunoglobulin, APL: IgA phospholipia units